Cristin-resultat-ID: 396417
Sist endret: 21. oktober 2013, 12:13
Resultat
Vitenskapelig artikkel
2004

Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report

Bidragsytere:
  • K Søndenaa
  • F Heinle
  • L Fjetland
  • E Gudlaugsson og
  • Unni Syversen

Tidsskrift

World Journal of Surgery
ISSN 0364-2313
e-ISSN 1432-2323
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2004
Volum: 28
Sider: 890 - 895

Beskrivelse Beskrivelse

Tittel

Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report

Sammendrag

Recent publications indicate that life may be prolonged by surgical debulking of neuroendocrine tumors. A minimum 90% reduction of liver metastases has been suggested to alleviate symptoms of the carcinoid. We have used the tumor marker chromogranin A (CgA) to assess hepatic resection in patients with neuroendocrine metastatic tumor disease. Since 1998, seven patients (3 men) of median age 73 years (range 64-84 years) with carcinoid primary tumors in the ileum who had solitary (n = 2) or multiple (n = 5) liver metastases underwent hepatic resections. Two patients had synchronous small intestinal and liver resections; the rest had deferred hepatic resections after intestinal resection. Hormonal manifestations in the form of loose stools or diarrhea or flushing were observed in five patients, and five had abdominal symptoms from partial obstruction of the small bowel. The resection was deemed radical in five patients. Two patients with non-radical resection needed postoperative octreotide treatment, and symptoms were alleviated or improved in the others. All seven patients are alive with an observation period from 6 to 64 months (median 36 months). Median CgA (normal

Bidragsytere

K Søndenaa

  • Tilknyttet:
    Forfatter

F Heinle

  • Tilknyttet:
    Forfatter

L Fjetland

  • Tilknyttet:
    Forfatter

E Gudlaugsson

  • Tilknyttet:
    Forfatter

Unni Syversen

  • Tilknyttet:
    Forfatter
    ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet
1 - 5 av 5